1. Shields CL, Fasiuddin AF, Mashayekhi A, Shields JA.Conjunctival nevi: clinical features and natural course in 410 consecutive patients. Arch Ophthalmol. 2004; 122:167–75.
2. Shields CL, Regillo AC, Mellen PL. . Giant conjunctival ne-vus: clinical features and natural course in 32 cases. JAMA Ophthalmol. 2013; 131:857–63.
3. Tomita M, Goto H, Muramatsu R, Usui M.Treatment of large con-junctival nevus by resection and reconstruction using amniotic membrane. Graefes Arch Clin Exp Ophthalmol. 2006; 244:761–4.
Article
4. Shields CL, Demirci H, Karatza E, Shields JA.Clinical survey of 1643 melanocytic and nonmelanocytic conjunctival tumors. Ophthalmology. 2004; 111:1747–54.
Article
5. Levecq L, De Potter P, Jamart J.Conjunctival nevi clinical features and therapeutic outcomes. Ophthalmology. 2010; 117:35–40.
6. Shields CL, Markowitz JS, Belinsky I. . Conjunctival melano-ma: outcomes based on tumor origin in 382 consecutive cases. Ophthalmology. 2011; 118:389–95. e1-2.
Article
7. Shields CL, Shields JA, Gündüz K. . Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients. Arch Ophthalmol. 2000; 118:1497–507.
8. Oellers P, Karp CL.Management of pigmented conjunctival lesions. Ocul Surf. 2012; 10:251–63.
9. Shields CL, Belinsky I, Romanelli-Gobbi M. . Anterior segment optical coherence tomography of conjunctival nevus. Ophthalmology. 2011; 118:915–9.
Article
10. Jo DH, Lee MJ, Han YK, Kwon JW.Surgical treatment of ex-tensive conjunctival melanocytic nevus mimicking conjunctival melanoma. J Korean Ophthalmol Soc. 2010; 51:764–8.
Article